TABLE 4.
Mouse and founder line | Sex | Exptb | Phenotypea |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CD4 downregulation |
Thymocyte loss |
pLN total cell loss |
Effector/memory | Proteinuria | Nonlymphoid organ diseasesc | |||||||||
Thymus | pLN | Total | CD4+ CD8− | CD8+ CD4− | CD4+ CD8+ | Total | CD4+ | CD8+ | ||||||
CD4C/rtTA × TRE/HIVNef | ||||||||||||||
F148571 | Maled | M | ++ | + | + | ++ | + | + | ++ | +++ | + | ++ | − | − |
Female | L | + | − | − | − | − | − | − | − | − | − | − | − | |
CD4C/rtTA2S-M2 × TRE/HIVNef | ||||||||||||||
F176042 | Maled | H | ++ | + | +++ | +++ | +++ | +++ | +++ | +++ | +++ | NDe | +++ | +++ |
Female | M | ++ | − | + | + | + | + | + | ++ | + | +++ | ++ | ++ | |
F176043 | Maled | H | ++ | ++ | +++ | +++ | ++ | +++ | +++ | +++ | +++ | NDe | +++ | +++ |
Female | M | ++ | − | − | + | + | − | ++ | ++ | ++ | ++ | ++ | + |
The most severe phenotype shown after DOX induction for each DTg line.
Nef expression: H, high; M, moderate; L, low.
Scored at 6 months after DOX induction, except for males of F176042 and F176043 lines, which were scored after 1 and 6 weeks.
All phenotypes seen within 6 weeks of DOX induction.
ND, not determined; the number of pLN T cells was too low to determine this phenotype.